{"gene":"RGS10","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1996,"finding":"RGS10 selectively associates with activated Gαi3 and Gαz (but not Gαs) via co-immunoprecipitation, and in vitro assays with purified proteins demonstrate that RGS10 potently increases GTP hydrolytic activity of Gαi3, Gαz, and Gα0, establishing RGS10 as a GTPase-activating protein (GAP) selective for the Gαi family.","method":"Co-immunoprecipitation; in vitro GTPase assay with purified proteins","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified proteins, replicated across labs","pmids":["8774883"],"is_preprint":false},{"year":1997,"finding":"The isolated RGS domain of RGS10 (120 amino acids) retains full GTPase-accelerating protein (GAP) activity toward Gαi1, Gαo, and Gαz in vitro, and short deletions within the RGS domain of the related RGS4 destroy both GAP activity and Gαi1 substrate binding.","method":"In vitro GTPase assay; domain deletion mutagenesis; surface plasmon resonance","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with domain mutagenesis, independent replication","pmids":["9207071"],"is_preprint":false},{"year":1999,"finding":"RGS10 is palmitoylated at a conserved Cys66 residue within its RGS domain; palmitoylation at this site inhibits GAP activity 80–100% in solution-based assays toward soluble Gαi/Gαz, but potentiates GAP activity ≥20-fold in receptor–G protein proteoliposome (membrane) assays, revealing context-dependent regulation of RGS10 activity by palmitoylation.","method":"[3H]palmitate metabolic labeling; site-directed mutagenesis (C66 → V); single-turnover GTPase assay; steady-state GTPase assay in proteoliposomes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis, two complementary assay systems","pmids":["10608901"],"is_preprint":false},{"year":2001,"finding":"RGS10 is phosphorylated at Ser168 by cAMP-dependent protein kinase A (PKA); this phosphorylation does not alter its intrinsic GAP activity toward Gα but causes translocation of RGS10 from the plasma membrane/cytosol to the nucleus, thereby attenuating its functional regulation of G protein-dependent GIRK channel activation at the membrane.","method":"Site-directed mutagenesis (S168A); phosphorylation assay; cellular fractionation; GIRK channel electrophysiology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis plus fractionation plus functional channel assay in one study","pmids":["11443111"],"is_preprint":false},{"year":2002,"finding":"Palmitoylation of RGS10 at the conserved Cys60 (equivalent to Cys66) is constitutive (not agonist-regulated), and mutation of this residue abolishes RGS10's negative regulatory action on GnRH receptor-stimulated inositol phosphate and cAMP production, demonstrating that this palmitoylation site is essential for RGS10 activity in mammalian signaling.","method":"Site-directed mutagenesis; [3H]palmitic acid labeling; inositol phosphate and cAMP reporter assays in GGH3 cells","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with functional signaling assays, confirms prior biochemical finding","pmids":["11897687"],"is_preprint":false},{"year":2005,"finding":"RGS10 protein is distributed across all cellular subcompartments of neurons and microglia, including nuclei (specifically euchromatin) and presynaptic terminals at symmetric synapses, as determined by light and electron microscopic immunohistochemistry in rodent brain; nuclear enrichment in transcriptionally active regions suggests a gene-regulatory role.","method":"Light microscopy and electron microscopy immunohistochemistry; dual immunofluorescence in rat and mouse brain","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 — direct subcellular localization by EM with anatomical specificity, but functional consequence not directly tested","pmids":["15593368"],"is_preprint":false},{"year":2005,"finding":"Crystals of the human RGS10 RGS domain complexed with human Gαi3 were obtained, diffraction data collected to 2.5 Å, confirming a direct physical complex between RGS10 and Gαi3 amenable to structural analysis.","method":"Protein crystallization; X-ray crystallography (2.5 Å resolution, synchrotron)","journal":"Acta crystallographica. Section F, Structural biology and crystallization communications","confidence":"Medium","confidence_rationale":"Tier 1 — crystallographic evidence of RGS10–Gαi3 complex; preliminary report without full structure determination","pmids":["16511171"],"is_preprint":false},{"year":2007,"finding":"In RGS10-null mice, RANKL-induced [Ca2+]i oscillations and NFATc1 activation are absent in osteoclast precursors; RGS10 competitively interacts with Ca2+/calmodulin and PIP3 in a [Ca2+]i-dependent manner to mediate PLCγ activation, placing RGS10 as an essential mediator of the RANKL→RGS10/calmodulin→[Ca2+]i oscillation→calcineurin→NFATc1 signaling axis required for osteoclast differentiation.","method":"RGS10-knockout mouse model; calcium imaging; ectopic NFATc1 rescue; biochemical interaction assays (competitive binding with calmodulin and PIP3); osteoclast differentiation assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO phenotype, calcium imaging, competitive binding assay, and rescue experiment in one study","pmids":["17626792"],"is_preprint":false},{"year":2008,"finding":"Endogenous RGS10 exerts GAP activity on the Gαi protein mediating GIRK channel activation in atrial myocytes; PKA-dependent phosphorylation of RGS10 at Ser168 (abolished by S168A mutation) enables beta-adrenergic receptor crosstalk to prolong GIRK channel deactivation kinetics, as shown by adenoviral overexpression and shRNA silencing.","method":"Adenoviral overexpression and shRNA knockdown; patch-clamp electrophysiology; PKA inhibition; site-directed mutagenesis (S168A) in rat atrial myocytes","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function with mutagenesis and functional electrophysiology, confirms PKA phosphorylation mechanism","pmids":["18276732"],"is_preprint":false},{"year":2011,"finding":"RGS10 functions as an inhibitor of Gαi-dependent, chemokine-upregulated T cell adhesion mediated by α4β1 and αLβ2 integrins; specifically, RGS10 opposes activation of the Vav1–Rac1 pathway downstream of chemokine receptor signaling to repress adhesion strengthening and spreading phases; constitutively active Rac1 rescues CXCL12-stimulated adhesion in RGS10-overexpressing cells.","method":"siRNA knockdown and overexpression in human T cells; shear stress detachment assay; cell spreading assay; Rac1/Vav1 activation assays; rescue with constitutively active Rac1","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal loss/gain-of-function, epistasis via constitutively active Rac1 rescue, multiple orthogonal readouts","pmids":["21705617"],"is_preprint":false},{"year":2012,"finding":"Stable overexpression of RGS10 in MN9D dopaminergic neuroblastoma cells confers resistance to TNF-induced cytotoxicity; this neuroprotective effect requires PKA-mediated phosphorylation of Ser168 (S168A mutant loses protection) and is mediated through PKA→phospho-CREB signaling, not ERK1/2, JNK, or NF-κB.","method":"Stable overexpression of WT and S168A RGS10; TNF cytotoxicity assay; pharmacological pathway inhibition; phospho-CREB biochemical analysis in MN9D cells","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis, pharmacological epistasis, and multiple negative controls establish pathway","pmids":["22564151"],"is_preprint":false},{"year":2013,"finding":"RGS10-null macrophages produce higher pro-inflammatory cytokines (TNF, IL-1β, IL-12p70) upon LPS stimulation and display blunted M2 alternative activation (lower YM1, Fizz1, reduced phagocytosis) upon IL-4 priming, demonstrating that RGS10 is required for proper M1/M2 macrophage activation balance.","method":"Rgs10-/- peritoneal and bone marrow-derived macrophages; cytokine ELISA; qPCR; phagocytosis and chemotaxis assays","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple functional readouts in two macrophage populations","pmids":["24278459"],"is_preprint":false},{"year":2014,"finding":"In chemoresistant ovarian cancer cells, HDAC1 and DNMT1 directly associate with RGS10 promoters; knockdown of HDAC1 or DNMT1 or pharmacological inhibition of their enzymatic activities increases RGS10 expression and cisplatin sensitivity; DNMT1 knockdown also reduces HDAC1 binding to RGS10 promoters, indicating HDAC1 recruitment requires DNMT1 activity.","method":"Chromatin immunoprecipitation (ChIP); siRNA knockdown; pharmacological enzyme inhibition; cell viability assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — ChIP with direct promoter binding, siRNA, and pharmacological inhibition with epistasis between DNMT1 and HDAC1","pmids":["24475290"],"is_preprint":false},{"year":2015,"finding":"Suppression of RGS10 in ovarian cancer cells increases GTP-bound Rheb (Rheb-GTP) and activates downstream mTOR signaling (phospho-mTOR, 4E-BP1, p70S6K, S6), and this is potentiated by LPA and blocked by mTOR inhibitors, indicating RGS10 acts as a GAP for the small GTPase Rheb to antagonize mTOR pathway activation.","method":"siRNA knockdown; GTP-Rheb pull-down assay; immunoblotting for mTOR pathway effectors; pharmacological mTOR inhibition","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2–3 — Rheb-GTP pull-down plus downstream signaling, single lab, novel non-canonical substrate","pmids":["26319900"],"is_preprint":false},{"year":2016,"finding":"HDAC enzyme activity is required for LPS-induced silencing of Rgs10 transcription in microglia; LPS activation deacetylates H3 histones at the Rgs10 proximal promoter and increases HDAC1 association at that promoter, as demonstrated by ChIP; HDAC inhibitor trichostatin A blocks LPS-induced RGS10 suppression.","method":"Chromatin immunoprecipitation (ChIP); HDAC inhibitor treatment; LPS-activation model in BV-2 and primary microglia; nerve injury mouse model","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — ChIP showing direct HDAC1 binding and histone deacetylation at Rgs10 promoter, validated in vivo and in vitro","pmids":["28031332"],"is_preprint":false},{"year":2018,"finding":"RGS10 loss in platelets enhances Gq- and Gi-mediated signaling (greater maximum responses to ADP and TxA2) but not G13-mediated shape change; in resting platelets, RGS10 is bound to scaffold proteins spinophilin and 14-3-3γ, and platelet activation or prostacyclin treatment releases free RGS10, demonstrating active regulation of RGS10 availability as a signaling node.","method":"RGS10-/- mouse platelets; aggregation, secretion, integrin activation assays; signaling immunoblotting; co-immunoprecipitation with spinophilin and 14-3-3γ; in vivo thrombosis model","journal":"Blood advances","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with agonist-specific signaling dissection, reciprocal Co-IP of scaffold binding partners, in vivo model","pmids":["30150297"],"is_preprint":false},{"year":2018,"finding":"Loss of RGS10 expression significantly elevates LPS-stimulated COX-2 expression and PGE2 production in microglia; this effect is not blocked by Gαi inhibition (pertussis toxin), and an RGS10 mutant unable to bind activated G proteins inhibits TNFα expression as effectively as wild-type RGS10, demonstrating that RGS10 regulates COX-2 and TNFα through a G protein-independent mechanism.","method":"siRNA knockdown; RGS10 G protein-binding mutant overexpression; Gαi inhibition with pertussis toxin; PGE2 ELISA; COX-2 immunoblot in microglia and ovarian cancer cells","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis of G protein interface, pharmacological Gi blockade, and two cell types establish G protein-independent mechanism","pmids":["30049816"],"is_preprint":false},{"year":2021,"finding":"Human RGS10 variants p.E163del and p.A171S retain intact GAP activity but show aberrant PKA-mediated phosphorylation patterns and increased cytosolic/membrane localization compared to wild-type RGS10, resulting in profoundly reduced lymphocyte chemotaxis; this mislocalization of RGS10 to the cytosol attenuates downstream chemokine signaling.","method":"Patient variants expressed in cells; GAP activity assay; PKA phosphorylation assay; subcellular fractionation/localization; lymphocyte chemotaxis assay","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1–2 — human disease variants with enzymatic assay, phosphorylation assay, localization and functional chemotaxis data in one study","pmids":["34315806"],"is_preprint":false},{"year":2021,"finding":"LPS-induced silencing of Rgs10 in pulmonary macrophages requires sequential PI3K/NF-κB/p300/TNF-α signaling and HDAC(1–3) activity; pharmacological inhibition of any step in this cascade blocks LPS-induced Rgs10 suppression; CRISPR/Cas9 deletion of RGS10 amplifies NF-κB phosphorylation and inflammatory gene expression, confirming RGS10 as a negative regulator of NF-κB.","method":"Pharmacological inhibition of PI3K, NF-κB, p300, TNF-α; HDAC inhibition; CRISPR/Cas9 RGS10 knockout; qPCR; immunoblotting in MH-S alveolar macrophages, BV2 microglia, BMDMs","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 2 — CRISPR KO plus pharmacological epistasis across multiple cell types, multiple pathway steps tested","pmids":["34339853"],"is_preprint":false},{"year":2024,"finding":"RGS10 interacts with PTPN2 (protein tyrosine phosphatase non-receptor type 2) in CD4+ T cells, as shown by co-immunoprecipitation; this interaction mediates RGS10 regulation of Th1 and Th17 cell differentiation by inhibiting STAT1 and STAT3 phosphorylation.","method":"Co-immunoprecipitation; RGS10 knockout mouse DSS-colitis model; flow cytometry of T cell subsets; phospho-STAT1/STAT3 immunoblotting; single-cell RNA sequencing","journal":"Immunology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP identifies novel binding partner, KO mouse with functional T cell phenotype, but mechanism linking PTPN2 interaction to STAT inhibition is not fully reconstituted","pmids":["39428350"],"is_preprint":false}],"current_model":"RGS10 is a small GTPase-activating protein that selectively accelerates GTP hydrolysis on Gαi/o/z subunits via its conserved RGS domain; its activity and localization are dynamically regulated by palmitoylation at a conserved RGS-domain cysteine (which is inhibitory in solution but stimulatory at membranes) and by PKA-mediated phosphorylation at Ser168 (which causes nuclear translocation without altering intrinsic GAP activity); beyond its canonical GAP function, RGS10 inhibits NF-κB-driven inflammatory gene expression (including COX-2 and TNFα) through a G protein-independent mechanism, regulates [Ca2+]i oscillations and NFATc1 activation in osteoclasts by competitively interacting with calmodulin and PIP3, suppresses mTOR signaling partly through GAP activity toward Rheb, and in resting platelets is sequestered by spinophilin and 14-3-3γ scaffold proteins to be released upon activation, collectively placing RGS10 as a multifunctional, actively regulated node that attenuates GPCR, inflammatory, and mTOR signaling in immune, neuronal, and hematopoietic cells."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of RGS10 as a Gαi-family-selective GAP resolved the question of which G protein subunits it regulates, establishing its core molecular activity.","evidence":"Co-immunoprecipitation and in vitro GTPase assays with purified Gα subunits","pmids":["8774883"],"confidence":"High","gaps":["Structural basis of Gαi selectivity not determined","Physiological context of GAP activity unknown"]},{"year":1997,"claim":"Demonstration that the isolated 120-amino-acid RGS domain retains full GAP activity established that no flanking regions are required for catalysis, defining the minimal functional unit.","evidence":"In vitro GTPase assay with domain truncation and deletion mutagenesis","pmids":["9207071"],"confidence":"High","gaps":["Role of non-RGS-domain regions in regulation or localization unclear"]},{"year":1999,"claim":"Discovery that palmitoylation at Cys66 inhibits GAP activity in solution but potentiates it ~20-fold at membranes revealed a context-dependent regulatory switch governing RGS10 function at its site of action.","evidence":"[³H]palmitate labeling, C66V mutagenesis, single-turnover and proteoliposome GTPase assays","pmids":["10608901"],"confidence":"High","gaps":["Enzyme(s) catalyzing palmitoylation not identified","In vivo confirmation of membrane-potentiation mechanism not provided"]},{"year":2001,"claim":"PKA phosphorylation at Ser168 was shown to relocalize RGS10 from the plasma membrane to the nucleus without altering intrinsic GAP activity, establishing a mechanism by which cAMP signaling disengages RGS10 from membrane-localized G proteins.","evidence":"S168A mutagenesis, subcellular fractionation, GIRK channel electrophysiology","pmids":["11443111"],"confidence":"High","gaps":["Nuclear function of phospho-RGS10 unknown","Whether 14-3-3 or other adaptors mediate nuclear retention not tested"]},{"year":2002,"claim":"Confirmation that palmitoylation is constitutive (not agonist-regulated) and essential for RGS10 to suppress GnRH receptor signaling validated the palmitoylation switch in a cellular GPCR signaling context.","evidence":"C60 mutagenesis, [³H]palmitate labeling, IP and cAMP reporter assays in GGH3 cells","pmids":["11897687"],"confidence":"High","gaps":["Whether depalmitoylation is actively regulated remains unknown"]},{"year":2005,"claim":"Ultrastructural localization of RGS10 to neuronal euchromatin and presynaptic terminals suggested dual nuclear and synaptic functions beyond classical membrane-proximal GAP activity.","evidence":"Light and electron microscopy immunohistochemistry in rodent brain","pmids":["15593368"],"confidence":"Medium","gaps":["No direct evidence for a transcriptional regulatory function in neurons","Nuclear binding partners not identified"]},{"year":2007,"claim":"The discovery that RGS10-null osteoclast precursors lack RANKL-induced Ca²⁺ oscillations and NFATc1 activation, and that RGS10 competitively binds calmodulin and PIP3, established a non-canonical, G protein-independent role in osteoclast differentiation.","evidence":"Rgs10 knockout mice, calcium imaging, competitive binding assays, NFATc1 rescue","pmids":["17626792"],"confidence":"High","gaps":["Direct structural basis for RGS10–calmodulin and RGS10–PIP3 interactions not resolved","Whether this mechanism operates in other cell types unknown"]},{"year":2008,"claim":"Endogenous RGS10 was confirmed as the functionally relevant GAP governing GIRK channel deactivation in cardiac atrial myocytes, with PKA-mediated Ser168 phosphorylation mediating β-adrenergic crosstalk.","evidence":"Adenoviral overexpression and shRNA knockdown, patch-clamp electrophysiology, S168A mutagenesis in rat atrial myocytes","pmids":["18276732"],"confidence":"High","gaps":["Relative contributions of RGS10 versus other RGS proteins in cardiac physiology not fully delineated"]},{"year":2011,"claim":"RGS10 was shown to oppose chemokine-driven T cell adhesion strengthening by attenuating Gαi-dependent Vav1–Rac1 activation, placing it as a negative regulator of integrin-mediated immune cell trafficking.","evidence":"siRNA/overexpression in T cells, shear-stress adhesion assay, constitutively active Rac1 rescue","pmids":["21705617"],"confidence":"High","gaps":["Whether RGS10 directly interacts with Vav1 or acts solely through Gαi not determined"]},{"year":2012,"claim":"RGS10-mediated neuroprotection against TNF cytotoxicity was shown to require PKA phosphorylation at Ser168 and to operate through a PKA→phospho-CREB pathway, linking the nuclear translocation event to a survival output.","evidence":"Stable overexpression of WT and S168A RGS10, pharmacological pathway inhibition, phospho-CREB analysis in MN9D cells","pmids":["22564151"],"confidence":"High","gaps":["Direct transcriptional targets of the RGS10–CREB axis not identified","In vivo neuroprotection not demonstrated"]},{"year":2013,"claim":"RGS10-null macrophages exhibited exaggerated M1 and impaired M2 responses, establishing RGS10 as a required checkpoint for macrophage polarization balance.","evidence":"Rgs10⁻/⁻ peritoneal and bone marrow-derived macrophages, cytokine ELISA, phagocytosis assays","pmids":["24278459"],"confidence":"High","gaps":["Molecular mechanism linking RGS10 to M2 gene induction not elucidated"]},{"year":2014,"claim":"HDAC1 and DNMT1 were found to directly bind RGS10 promoters and silence its expression in chemoresistant ovarian cancer cells, revealing an epigenetic mechanism of RGS10 downregulation with therapeutic implications.","evidence":"ChIP, siRNA knockdown, HDAC/DNMT inhibition, cisplatin sensitivity assay","pmids":["24475290"],"confidence":"High","gaps":["Specific CpG methylation sites at RGS10 promoter not mapped","In vivo therapeutic validation lacking"]},{"year":2015,"claim":"RGS10 suppression elevated GTP-bound Rheb and activated mTOR effectors, suggesting RGS10 acts as a GAP for the small GTPase Rheb to restrain mTOR signaling—a non-canonical substrate outside the Gαi family.","evidence":"siRNA knockdown, GTP-Rheb pull-down, mTOR pathway immunoblotting, pharmacological mTOR inhibition","pmids":["26319900"],"confidence":"Medium","gaps":["Direct GAP activity toward Rheb not reconstituted with purified proteins","Single-lab finding without independent replication","Structural basis for Rheb recognition not addressed"]},{"year":2016,"claim":"LPS-induced HDAC1 recruitment and histone deacetylation at the Rgs10 promoter in microglia established a feed-forward inflammatory loop: inflammation silences RGS10, which in turn amplifies inflammation.","evidence":"ChIP for HDAC1 and acetyl-H3 at Rgs10 promoter, HDAC inhibitor treatment, LPS activation in BV2/primary microglia and nerve injury model","pmids":["28031332"],"confidence":"High","gaps":["Whether other HDACs contribute in vivo not fully resolved"]},{"year":2018,"claim":"Two key advances established that (1) RGS10 inhibits COX-2 and TNFα through a mechanism independent of G protein binding, and (2) in platelets, RGS10 is sequestered by spinophilin/14-3-3γ and released upon activation, defining both a G protein-independent anti-inflammatory pathway and a scaffold-regulated availability mechanism.","evidence":"G protein-binding-deficient RGS10 mutant retaining anti-inflammatory function; pertussis toxin insensitivity; RGS10⁻/⁻ platelet signaling assays; co-IP with spinophilin and 14-3-3γ; in vivo thrombosis model","pmids":["30049816","30150297"],"confidence":"High","gaps":["Direct target of G protein-independent anti-inflammatory action not identified","Structural basis for spinophilin/14-3-3γ sequestration unknown"]},{"year":2021,"claim":"A full PI3K→NF-κB→p300→TNFα→HDAC1-3 signaling cascade was delineated for LPS-induced RGS10 silencing, and human RGS10 variants with altered PKA phosphorylation and mislocalization were linked to defective lymphocyte chemotaxis, connecting variant biology to immune function.","evidence":"Pharmacological epistasis and CRISPR KO in macrophages; patient-derived variant expression with GAP, phosphorylation, localization, and chemotaxis assays","pmids":["34339853","34315806"],"confidence":"High","gaps":["Clinical phenotype spectrum of human RGS10 variants not fully defined","Whether variants affect non-immune RGS10 functions not tested"]},{"year":2024,"claim":"RGS10 was found to interact with the phosphatase PTPN2 in CD4⁺ T cells, mediating inhibition of STAT1/STAT3 phosphorylation and restricting Th1/Th17 differentiation, extending RGS10's immune-regulatory reach to JAK-STAT signaling.","evidence":"Co-immunoprecipitation, RGS10 KO DSS-colitis mouse model, phospho-STAT immunoblotting, scRNA-seq","pmids":["39428350"],"confidence":"Medium","gaps":["PTPN2–RGS10 interaction not validated by reciprocal IP or with purified proteins","Whether PTPN2 interaction is direct or part of a larger complex not resolved","Mechanistic link between RGS10 binding and PTPN2 phosphatase activity not established"]},{"year":null,"claim":"Key unresolved questions include the identity of RGS10's direct target in G protein-independent NF-κB suppression, whether RGS10 is a bona fide Rheb GAP, the structural basis for its interactions with calmodulin/PIP3/spinophilin/14-3-3γ, and the full phenotypic spectrum of human RGS10 deficiency.","evidence":"","pmids":[],"confidence":"Low","gaps":["Direct molecular target of G protein-independent anti-inflammatory activity unidentified","Rheb GAP activity not reconstituted with purified components","No high-resolution structure of full-length RGS10 or its complexes with non-Gα partners"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,1,2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,9,16,18]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,13]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,5,15]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,17]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,8,9,15]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,11,16,18,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[10]}],"complexes":[],"partners":["GNAI3","GNAZ","GNAO1","SPP1","YWHAG","PTPN2","CALM1"],"other_free_text":[]},"mechanistic_narrative":"RGS10 is a multifunctional signaling regulator that accelerates GTP hydrolysis on Gαi/o/z subunits and additionally suppresses inflammatory and mTOR signaling through G protein-independent mechanisms. Its conserved RGS domain is sufficient for GAP activity toward Gαi family members, and this activity is dynamically modulated by palmitoylation at Cys66—inhibitory in solution but stimulatory at membranes—and by PKA phosphorylation at Ser168, which drives nuclear translocation without altering intrinsic catalytic function [PMID:8774883, PMID:10608901, PMID:11443111]. Beyond canonical GAP function, RGS10 inhibits NF-κB-driven inflammatory gene expression (COX-2, TNFα) through a mechanism independent of Gαi binding, regulates RANKL-induced calcium oscillations and NFATc1 activation in osteoclasts via competitive interactions with calmodulin and PIP3, and attenuates mTOR signaling by promoting GTP hydrolysis on Rheb [PMID:30049816, PMID:17626792, PMID:26319900]. In resting platelets, RGS10 is sequestered by spinophilin and 14-3-3γ and released upon activation to dampen Gq and Gi signaling, while in macrophages and microglia its transcription is silenced by LPS through HDAC1/DNMT1-mediated epigenetic repression, creating a feed-forward inflammatory loop that RGS10 normally restrains [PMID:30150297, PMID:28031332, PMID:34339853]."},"prefetch_data":{"uniprot":{"accession":"O43665","full_name":"Regulator of G-protein signaling 10","aliases":[],"length_aa":181,"mass_kda":21.2,"function":"Regulates G protein-coupled receptor signaling cascades, including signaling downstream of the muscarinic acetylcholine receptor CHRM2. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:10608901, PubMed:11443111, PubMed:18434541, PubMed:8774883, PubMed:9353196). Modulates the activity of potassium channels that are activated in response to CHRM2 signaling (PubMed:11443111). Activity on GNAZ is inhibited by palmitoylation of the G-protein (PubMed:9353196)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O43665/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RGS10","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RGS10","total_profiled":1310},"omim":[{"mim_id":"602856","title":"REGULATOR OF G PROTEIN SIGNALING 10; RGS10","url":"https://www.omim.org/entry/602856"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":207.4}],"url":"https://www.proteinatlas.org/search/RGS10"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O43665","domains":[{"cath_id":"1.10.167.10","chopping":"43-161","consensus_level":"high","plddt":92.8319,"start":43,"end":161}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43665","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43665-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43665-F1-predicted_aligned_error_v6.png","plddt_mean":81.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RGS10","jax_strain_url":"https://www.jax.org/strain/search?query=RGS10"},"sequence":{"accession":"O43665","fasta_url":"https://rest.uniprot.org/uniprotkb/O43665.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43665/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43665"}},"corpus_meta":[{"pmid":"8774883","id":"PMC_8774883","title":"RGS10 is a selective activator of G alpha i GTPase activity.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8774883","citation_count":321,"is_preprint":false},{"pmid":"9207071","id":"PMC_9207071","title":"The regulators of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity in vitro.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9207071","citation_count":155,"is_preprint":false},{"pmid":"17626792","id":"PMC_17626792","title":"RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17626792","citation_count":112,"is_preprint":false},{"pmid":"10608901","id":"PMC_10608901","title":"Palmitoylation of a conserved cysteine in the regulator of G protein signaling (RGS) domain modulates the GTPase-activating activity of RGS4 and RGS10.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608901","citation_count":88,"is_preprint":false},{"pmid":"11443111","id":"PMC_11443111","title":"Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10).","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11443111","citation_count":82,"is_preprint":false},{"pmid":"24475290","id":"PMC_24475290","title":"Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24475290","citation_count":78,"is_preprint":false},{"pmid":"21044322","id":"PMC_21044322","title":"Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21044322","citation_count":67,"is_preprint":false},{"pmid":"24278459","id":"PMC_24278459","title":"Critical role of regulator G-protein signaling 10 (RGS10) in modulating macrophage M1/M2 activation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24278459","citation_count":44,"is_preprint":false},{"pmid":"23533674","id":"PMC_23533674","title":"Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23533674","citation_count":40,"is_preprint":false},{"pmid":"24761229","id":"PMC_24761229","title":"Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.","date":"2013","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/24761229","citation_count":39,"is_preprint":false},{"pmid":"21705617","id":"PMC_21705617","title":"RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/21705617","citation_count":34,"is_preprint":false},{"pmid":"11897687","id":"PMC_11897687","title":"Regulation of RGS3 and RGS10 palmitoylation by GnRH.","date":"2002","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11897687","citation_count":34,"is_preprint":false},{"pmid":"28031332","id":"PMC_28031332","title":"Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity.","date":"2016","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28031332","citation_count":33,"is_preprint":false},{"pmid":"18276732","id":"PMC_18276732","title":"A role for RGS10 in beta-adrenergic modulation of G-protein-activated K+ (GIRK) channel current in rat atrial myocytes.","date":"2008","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18276732","citation_count":32,"is_preprint":false},{"pmid":"22564151","id":"PMC_22564151","title":"RGS10 exerts a neuroprotective role through the PKA/c-AMP response-element (CREB) pathway in dopaminergic neuron-like cells.","date":"2012","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22564151","citation_count":28,"is_preprint":false},{"pmid":"15593368","id":"PMC_15593368","title":"Regional, cellular, and subcellular localization of RGS10 in rodent brain.","date":"2005","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15593368","citation_count":26,"is_preprint":false},{"pmid":"26831924","id":"PMC_26831924","title":"RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.","date":"2016","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26831924","citation_count":25,"is_preprint":false},{"pmid":"27829061","id":"PMC_27829061","title":"RGS10 Negatively Regulates Platelet Activation and Thrombogenesis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27829061","citation_count":24,"is_preprint":false},{"pmid":"26319900","id":"PMC_26319900","title":"Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.","date":"2015","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/26319900","citation_count":23,"is_preprint":false},{"pmid":"30049816","id":"PMC_30049816","title":"RGS10 Regulates the Expression of Cyclooxygenase-2 and Tumor Necrosis Factor Alpha through a G Protein-Independent Mechanism.","date":"2018","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30049816","citation_count":23,"is_preprint":false},{"pmid":"25784210","id":"PMC_25784210","title":"Age-related changes in regulator of G-protein signaling (RGS)-10 expression in peripheral and central immune cells may influence the risk for age-related degeneration.","date":"2015","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/25784210","citation_count":20,"is_preprint":false},{"pmid":"32542378","id":"PMC_32542378","title":"RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survival.","date":"2020","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/32542378","citation_count":19,"is_preprint":false},{"pmid":"26123306","id":"PMC_26123306","title":"Physiology of RGS10 in Neurons and Immune Cells.","date":"2015","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/26123306","citation_count":18,"is_preprint":false},{"pmid":"26902301","id":"PMC_26902301","title":"Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.","date":"2016","source":"The AAPS journal","url":"https://pubmed.ncbi.nlm.nih.gov/26902301","citation_count":18,"is_preprint":false},{"pmid":"30150297","id":"PMC_30150297","title":"RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists.","date":"2018","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/30150297","citation_count":16,"is_preprint":false},{"pmid":"36041584","id":"PMC_36041584","title":"Inhibition of RGS10 Aggravates Periapical Periodontitis via Upregulation of the NF-κB Pathway.","date":"2022","source":"Journal of endodontics","url":"https://pubmed.ncbi.nlm.nih.gov/36041584","citation_count":12,"is_preprint":false},{"pmid":"34339853","id":"PMC_34339853","title":"PI3K/ NF-κB-dependent TNF-α and HDAC activities facilitate LPS-induced RGS10 suppression in pulmonary macrophages.","date":"2021","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/34339853","citation_count":12,"is_preprint":false},{"pmid":"35810565","id":"PMC_35810565","title":"RGS10 suppression by DNA methylation is associated with low survival rates in colorectal carcinoma.","date":"2022","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/35810565","citation_count":11,"is_preprint":false},{"pmid":"34912341","id":"PMC_34912341","title":"RGS10 Reduces Lethal Influenza Infection and Associated Lung Inflammation in Mice.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34912341","citation_count":11,"is_preprint":false},{"pmid":"26293348","id":"PMC_26293348","title":"Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer.","date":"2015","source":"Future medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26293348","citation_count":10,"is_preprint":false},{"pmid":"20816714","id":"PMC_20816714","title":"Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain.","date":"2010","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/20816714","citation_count":9,"is_preprint":false},{"pmid":"35122384","id":"PMC_35122384","title":"Inhibition of Rgs10 aggravates periodontitis with collagen-induced arthritis via the nuclear factor-κB pathway.","date":"2022","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35122384","citation_count":6,"is_preprint":false},{"pmid":"38812790","id":"PMC_38812790","title":"RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia.","date":"2024","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38812790","citation_count":6,"is_preprint":false},{"pmid":"37092953","id":"PMC_37092953","title":"RGS10 negatively regulates apical periodontitis via TFEB-mediated autophagy in BABL/c mice model and in vitro.","date":"2023","source":"International endodontic journal","url":"https://pubmed.ncbi.nlm.nih.gov/37092953","citation_count":6,"is_preprint":false},{"pmid":"34315806","id":"PMC_34315806","title":"Short stature and combined immunodeficiency associated with mutations in RGS10.","date":"2021","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34315806","citation_count":5,"is_preprint":false},{"pmid":"34737809","id":"PMC_34737809","title":"miR-199b-5p mediates adriamycin-induced podocyte apoptosis by inhibiting the expression of RGS10.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34737809","citation_count":5,"is_preprint":false},{"pmid":"39428350","id":"PMC_39428350","title":"RGS10 Deficiency Alleviated Intestinal Mucosal Inflammation Through Suppression of Th1/Th17 Cell Immune Responses in Ulcerative Colitis.","date":"2024","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39428350","citation_count":4,"is_preprint":false},{"pmid":"39547663","id":"PMC_39547663","title":"A Phenotypic High-Throughput Screen Identifies Small Molecule Modulators of Endogenous RGS10 in BV-2 Cells.","date":"2024","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39547663","citation_count":4,"is_preprint":false},{"pmid":"38331118","id":"PMC_38331118","title":"Epigenetic insights into Familial Mediterranean Fever: Increased RGS10 expression and histone modifications accompanies inflammation in familial Mediterranean fever disease.","date":"2024","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/38331118","citation_count":3,"is_preprint":false},{"pmid":"39145770","id":"PMC_39145770","title":"RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39145770","citation_count":3,"is_preprint":false},{"pmid":"12644305","id":"PMC_12644305","title":"A Galphas mutation (D229S) differentially effects gonadotropin-releasing hormone receptor regulation by RGS10, RGS3 and RGS3T.","date":"2003","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12644305","citation_count":3,"is_preprint":false},{"pmid":"37879890","id":"PMC_37879890","title":"RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.","date":"2023","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/37879890","citation_count":1,"is_preprint":false},{"pmid":"39554164","id":"PMC_39554164","title":"RGS10 Attenuates Systemic Immune Dysregulation Induced by Chronic Inflammatory Stress.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39554164","citation_count":1,"is_preprint":false},{"pmid":"41727175","id":"PMC_41727175","title":"RGS10 differentially modulates NFKB subunit transcription and inflammatory cytokine profiles in peritoneal macrophages.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41727175","citation_count":0,"is_preprint":false},{"pmid":"16511171","id":"PMC_16511171","title":"Crystallization and preliminary X-ray crystallographic analysis of human RGS10 complexed with Galphai3.","date":"2005","source":"Acta crystallographica. Section F, Structural biology and crystallization communications","url":"https://pubmed.ncbi.nlm.nih.gov/16511171","citation_count":0,"is_preprint":false},{"pmid":"39994765","id":"PMC_39994765","title":"RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress.","date":"2025","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/39994765","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.09.26.615202","title":"The glia club: Validation of polarization biomarkers for human microglia (HMC3) using quantitative real time RT-qPCR","date":"2024-09-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.26.615202","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25703,"output_tokens":5384,"usd":0.078935},"stage2":{"model":"claude-opus-4-6","input_tokens":9057,"output_tokens":4029,"usd":0.219015},"total_usd":0.29795,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS10 selectively associates with activated Gαi3 and Gαz (but not Gαs) via co-immunoprecipitation, and in vitro assays with purified proteins demonstrate that RGS10 potently increases GTP hydrolytic activity of Gαi3, Gαz, and Gα0, establishing RGS10 as a GTPase-activating protein (GAP) selective for the Gαi family.\",\n      \"method\": \"Co-immunoprecipitation; in vitro GTPase assay with purified proteins\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified proteins, replicated across labs\",\n      \"pmids\": [\"8774883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The isolated RGS domain of RGS10 (120 amino acids) retains full GTPase-accelerating protein (GAP) activity toward Gαi1, Gαo, and Gαz in vitro, and short deletions within the RGS domain of the related RGS4 destroy both GAP activity and Gαi1 substrate binding.\",\n      \"method\": \"In vitro GTPase assay; domain deletion mutagenesis; surface plasmon resonance\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with domain mutagenesis, independent replication\",\n      \"pmids\": [\"9207071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"RGS10 is palmitoylated at a conserved Cys66 residue within its RGS domain; palmitoylation at this site inhibits GAP activity 80–100% in solution-based assays toward soluble Gαi/Gαz, but potentiates GAP activity ≥20-fold in receptor–G protein proteoliposome (membrane) assays, revealing context-dependent regulation of RGS10 activity by palmitoylation.\",\n      \"method\": \"[3H]palmitate metabolic labeling; site-directed mutagenesis (C66 → V); single-turnover GTPase assay; steady-state GTPase assay in proteoliposomes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis, two complementary assay systems\",\n      \"pmids\": [\"10608901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"RGS10 is phosphorylated at Ser168 by cAMP-dependent protein kinase A (PKA); this phosphorylation does not alter its intrinsic GAP activity toward Gα but causes translocation of RGS10 from the plasma membrane/cytosol to the nucleus, thereby attenuating its functional regulation of G protein-dependent GIRK channel activation at the membrane.\",\n      \"method\": \"Site-directed mutagenesis (S168A); phosphorylation assay; cellular fractionation; GIRK channel electrophysiology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis plus fractionation plus functional channel assay in one study\",\n      \"pmids\": [\"11443111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Palmitoylation of RGS10 at the conserved Cys60 (equivalent to Cys66) is constitutive (not agonist-regulated), and mutation of this residue abolishes RGS10's negative regulatory action on GnRH receptor-stimulated inositol phosphate and cAMP production, demonstrating that this palmitoylation site is essential for RGS10 activity in mammalian signaling.\",\n      \"method\": \"Site-directed mutagenesis; [3H]palmitic acid labeling; inositol phosphate and cAMP reporter assays in GGH3 cells\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with functional signaling assays, confirms prior biochemical finding\",\n      \"pmids\": [\"11897687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RGS10 protein is distributed across all cellular subcompartments of neurons and microglia, including nuclei (specifically euchromatin) and presynaptic terminals at symmetric synapses, as determined by light and electron microscopic immunohistochemistry in rodent brain; nuclear enrichment in transcriptionally active regions suggests a gene-regulatory role.\",\n      \"method\": \"Light microscopy and electron microscopy immunohistochemistry; dual immunofluorescence in rat and mouse brain\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization by EM with anatomical specificity, but functional consequence not directly tested\",\n      \"pmids\": [\"15593368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystals of the human RGS10 RGS domain complexed with human Gαi3 were obtained, diffraction data collected to 2.5 Å, confirming a direct physical complex between RGS10 and Gαi3 amenable to structural analysis.\",\n      \"method\": \"Protein crystallization; X-ray crystallography (2.5 Å resolution, synchrotron)\",\n      \"journal\": \"Acta crystallographica. Section F, Structural biology and crystallization communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — crystallographic evidence of RGS10–Gαi3 complex; preliminary report without full structure determination\",\n      \"pmids\": [\"16511171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In RGS10-null mice, RANKL-induced [Ca2+]i oscillations and NFATc1 activation are absent in osteoclast precursors; RGS10 competitively interacts with Ca2+/calmodulin and PIP3 in a [Ca2+]i-dependent manner to mediate PLCγ activation, placing RGS10 as an essential mediator of the RANKL→RGS10/calmodulin→[Ca2+]i oscillation→calcineurin→NFATc1 signaling axis required for osteoclast differentiation.\",\n      \"method\": \"RGS10-knockout mouse model; calcium imaging; ectopic NFATc1 rescue; biochemical interaction assays (competitive binding with calmodulin and PIP3); osteoclast differentiation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO phenotype, calcium imaging, competitive binding assay, and rescue experiment in one study\",\n      \"pmids\": [\"17626792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Endogenous RGS10 exerts GAP activity on the Gαi protein mediating GIRK channel activation in atrial myocytes; PKA-dependent phosphorylation of RGS10 at Ser168 (abolished by S168A mutation) enables beta-adrenergic receptor crosstalk to prolong GIRK channel deactivation kinetics, as shown by adenoviral overexpression and shRNA silencing.\",\n      \"method\": \"Adenoviral overexpression and shRNA knockdown; patch-clamp electrophysiology; PKA inhibition; site-directed mutagenesis (S168A) in rat atrial myocytes\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function with mutagenesis and functional electrophysiology, confirms PKA phosphorylation mechanism\",\n      \"pmids\": [\"18276732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RGS10 functions as an inhibitor of Gαi-dependent, chemokine-upregulated T cell adhesion mediated by α4β1 and αLβ2 integrins; specifically, RGS10 opposes activation of the Vav1–Rac1 pathway downstream of chemokine receptor signaling to repress adhesion strengthening and spreading phases; constitutively active Rac1 rescues CXCL12-stimulated adhesion in RGS10-overexpressing cells.\",\n      \"method\": \"siRNA knockdown and overexpression in human T cells; shear stress detachment assay; cell spreading assay; Rac1/Vav1 activation assays; rescue with constitutively active Rac1\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal loss/gain-of-function, epistasis via constitutively active Rac1 rescue, multiple orthogonal readouts\",\n      \"pmids\": [\"21705617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Stable overexpression of RGS10 in MN9D dopaminergic neuroblastoma cells confers resistance to TNF-induced cytotoxicity; this neuroprotective effect requires PKA-mediated phosphorylation of Ser168 (S168A mutant loses protection) and is mediated through PKA→phospho-CREB signaling, not ERK1/2, JNK, or NF-κB.\",\n      \"method\": \"Stable overexpression of WT and S168A RGS10; TNF cytotoxicity assay; pharmacological pathway inhibition; phospho-CREB biochemical analysis in MN9D cells\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis, pharmacological epistasis, and multiple negative controls establish pathway\",\n      \"pmids\": [\"22564151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RGS10-null macrophages produce higher pro-inflammatory cytokines (TNF, IL-1β, IL-12p70) upon LPS stimulation and display blunted M2 alternative activation (lower YM1, Fizz1, reduced phagocytosis) upon IL-4 priming, demonstrating that RGS10 is required for proper M1/M2 macrophage activation balance.\",\n      \"method\": \"Rgs10-/- peritoneal and bone marrow-derived macrophages; cytokine ELISA; qPCR; phagocytosis and chemotaxis assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple functional readouts in two macrophage populations\",\n      \"pmids\": [\"24278459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In chemoresistant ovarian cancer cells, HDAC1 and DNMT1 directly associate with RGS10 promoters; knockdown of HDAC1 or DNMT1 or pharmacological inhibition of their enzymatic activities increases RGS10 expression and cisplatin sensitivity; DNMT1 knockdown also reduces HDAC1 binding to RGS10 promoters, indicating HDAC1 recruitment requires DNMT1 activity.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); siRNA knockdown; pharmacological enzyme inhibition; cell viability assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with direct promoter binding, siRNA, and pharmacological inhibition with epistasis between DNMT1 and HDAC1\",\n      \"pmids\": [\"24475290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Suppression of RGS10 in ovarian cancer cells increases GTP-bound Rheb (Rheb-GTP) and activates downstream mTOR signaling (phospho-mTOR, 4E-BP1, p70S6K, S6), and this is potentiated by LPA and blocked by mTOR inhibitors, indicating RGS10 acts as a GAP for the small GTPase Rheb to antagonize mTOR pathway activation.\",\n      \"method\": \"siRNA knockdown; GTP-Rheb pull-down assay; immunoblotting for mTOR pathway effectors; pharmacological mTOR inhibition\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Rheb-GTP pull-down plus downstream signaling, single lab, novel non-canonical substrate\",\n      \"pmids\": [\"26319900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HDAC enzyme activity is required for LPS-induced silencing of Rgs10 transcription in microglia; LPS activation deacetylates H3 histones at the Rgs10 proximal promoter and increases HDAC1 association at that promoter, as demonstrated by ChIP; HDAC inhibitor trichostatin A blocks LPS-induced RGS10 suppression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); HDAC inhibitor treatment; LPS-activation model in BV-2 and primary microglia; nerve injury mouse model\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing direct HDAC1 binding and histone deacetylation at Rgs10 promoter, validated in vivo and in vitro\",\n      \"pmids\": [\"28031332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RGS10 loss in platelets enhances Gq- and Gi-mediated signaling (greater maximum responses to ADP and TxA2) but not G13-mediated shape change; in resting platelets, RGS10 is bound to scaffold proteins spinophilin and 14-3-3γ, and platelet activation or prostacyclin treatment releases free RGS10, demonstrating active regulation of RGS10 availability as a signaling node.\",\n      \"method\": \"RGS10-/- mouse platelets; aggregation, secretion, integrin activation assays; signaling immunoblotting; co-immunoprecipitation with spinophilin and 14-3-3γ; in vivo thrombosis model\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with agonist-specific signaling dissection, reciprocal Co-IP of scaffold binding partners, in vivo model\",\n      \"pmids\": [\"30150297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of RGS10 expression significantly elevates LPS-stimulated COX-2 expression and PGE2 production in microglia; this effect is not blocked by Gαi inhibition (pertussis toxin), and an RGS10 mutant unable to bind activated G proteins inhibits TNFα expression as effectively as wild-type RGS10, demonstrating that RGS10 regulates COX-2 and TNFα through a G protein-independent mechanism.\",\n      \"method\": \"siRNA knockdown; RGS10 G protein-binding mutant overexpression; Gαi inhibition with pertussis toxin; PGE2 ELISA; COX-2 immunoblot in microglia and ovarian cancer cells\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis of G protein interface, pharmacological Gi blockade, and two cell types establish G protein-independent mechanism\",\n      \"pmids\": [\"30049816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Human RGS10 variants p.E163del and p.A171S retain intact GAP activity but show aberrant PKA-mediated phosphorylation patterns and increased cytosolic/membrane localization compared to wild-type RGS10, resulting in profoundly reduced lymphocyte chemotaxis; this mislocalization of RGS10 to the cytosol attenuates downstream chemokine signaling.\",\n      \"method\": \"Patient variants expressed in cells; GAP activity assay; PKA phosphorylation assay; subcellular fractionation/localization; lymphocyte chemotaxis assay\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — human disease variants with enzymatic assay, phosphorylation assay, localization and functional chemotaxis data in one study\",\n      \"pmids\": [\"34315806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"LPS-induced silencing of Rgs10 in pulmonary macrophages requires sequential PI3K/NF-κB/p300/TNF-α signaling and HDAC(1–3) activity; pharmacological inhibition of any step in this cascade blocks LPS-induced Rgs10 suppression; CRISPR/Cas9 deletion of RGS10 amplifies NF-κB phosphorylation and inflammatory gene expression, confirming RGS10 as a negative regulator of NF-κB.\",\n      \"method\": \"Pharmacological inhibition of PI3K, NF-κB, p300, TNF-α; HDAC inhibition; CRISPR/Cas9 RGS10 knockout; qPCR; immunoblotting in MH-S alveolar macrophages, BV2 microglia, BMDMs\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO plus pharmacological epistasis across multiple cell types, multiple pathway steps tested\",\n      \"pmids\": [\"34339853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RGS10 interacts with PTPN2 (protein tyrosine phosphatase non-receptor type 2) in CD4+ T cells, as shown by co-immunoprecipitation; this interaction mediates RGS10 regulation of Th1 and Th17 cell differentiation by inhibiting STAT1 and STAT3 phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation; RGS10 knockout mouse DSS-colitis model; flow cytometry of T cell subsets; phospho-STAT1/STAT3 immunoblotting; single-cell RNA sequencing\",\n      \"journal\": \"Immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP identifies novel binding partner, KO mouse with functional T cell phenotype, but mechanism linking PTPN2 interaction to STAT inhibition is not fully reconstituted\",\n      \"pmids\": [\"39428350\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RGS10 is a small GTPase-activating protein that selectively accelerates GTP hydrolysis on Gαi/o/z subunits via its conserved RGS domain; its activity and localization are dynamically regulated by palmitoylation at a conserved RGS-domain cysteine (which is inhibitory in solution but stimulatory at membranes) and by PKA-mediated phosphorylation at Ser168 (which causes nuclear translocation without altering intrinsic GAP activity); beyond its canonical GAP function, RGS10 inhibits NF-κB-driven inflammatory gene expression (including COX-2 and TNFα) through a G protein-independent mechanism, regulates [Ca2+]i oscillations and NFATc1 activation in osteoclasts by competitively interacting with calmodulin and PIP3, suppresses mTOR signaling partly through GAP activity toward Rheb, and in resting platelets is sequestered by spinophilin and 14-3-3γ scaffold proteins to be released upon activation, collectively placing RGS10 as a multifunctional, actively regulated node that attenuates GPCR, inflammatory, and mTOR signaling in immune, neuronal, and hematopoietic cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RGS10 is a multifunctional signaling regulator that accelerates GTP hydrolysis on Gαi/o/z subunits and additionally suppresses inflammatory and mTOR signaling through G protein-independent mechanisms. Its conserved RGS domain is sufficient for GAP activity toward Gαi family members, and this activity is dynamically modulated by palmitoylation at Cys66—inhibitory in solution but stimulatory at membranes—and by PKA phosphorylation at Ser168, which drives nuclear translocation without altering intrinsic catalytic function [PMID:8774883, PMID:10608901, PMID:11443111]. Beyond canonical GAP function, RGS10 inhibits NF-κB-driven inflammatory gene expression (COX-2, TNFα) through a mechanism independent of Gαi binding, regulates RANKL-induced calcium oscillations and NFATc1 activation in osteoclasts via competitive interactions with calmodulin and PIP3, and attenuates mTOR signaling by promoting GTP hydrolysis on Rheb [PMID:30049816, PMID:17626792, PMID:26319900]. In resting platelets, RGS10 is sequestered by spinophilin and 14-3-3γ and released upon activation to dampen Gq and Gi signaling, while in macrophages and microglia its transcription is silenced by LPS through HDAC1/DNMT1-mediated epigenetic repression, creating a feed-forward inflammatory loop that RGS10 normally restrains [PMID:30150297, PMID:28031332, PMID:34339853].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of RGS10 as a Gαi-family-selective GAP resolved the question of which G protein subunits it regulates, establishing its core molecular activity.\",\n      \"evidence\": \"Co-immunoprecipitation and in vitro GTPase assays with purified Gα subunits\",\n      \"pmids\": [\"8774883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Gαi selectivity not determined\", \"Physiological context of GAP activity unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstration that the isolated 120-amino-acid RGS domain retains full GAP activity established that no flanking regions are required for catalysis, defining the minimal functional unit.\",\n      \"evidence\": \"In vitro GTPase assay with domain truncation and deletion mutagenesis\",\n      \"pmids\": [\"9207071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of non-RGS-domain regions in regulation or localization unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that palmitoylation at Cys66 inhibits GAP activity in solution but potentiates it ~20-fold at membranes revealed a context-dependent regulatory switch governing RGS10 function at its site of action.\",\n      \"evidence\": \"[³H]palmitate labeling, C66V mutagenesis, single-turnover and proteoliposome GTPase assays\",\n      \"pmids\": [\"10608901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enzyme(s) catalyzing palmitoylation not identified\", \"In vivo confirmation of membrane-potentiation mechanism not provided\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"PKA phosphorylation at Ser168 was shown to relocalize RGS10 from the plasma membrane to the nucleus without altering intrinsic GAP activity, establishing a mechanism by which cAMP signaling disengages RGS10 from membrane-localized G proteins.\",\n      \"evidence\": \"S168A mutagenesis, subcellular fractionation, GIRK channel electrophysiology\",\n      \"pmids\": [\"11443111\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear function of phospho-RGS10 unknown\", \"Whether 14-3-3 or other adaptors mediate nuclear retention not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Confirmation that palmitoylation is constitutive (not agonist-regulated) and essential for RGS10 to suppress GnRH receptor signaling validated the palmitoylation switch in a cellular GPCR signaling context.\",\n      \"evidence\": \"C60 mutagenesis, [³H]palmitate labeling, IP and cAMP reporter assays in GGH3 cells\",\n      \"pmids\": [\"11897687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether depalmitoylation is actively regulated remains unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Ultrastructural localization of RGS10 to neuronal euchromatin and presynaptic terminals suggested dual nuclear and synaptic functions beyond classical membrane-proximal GAP activity.\",\n      \"evidence\": \"Light and electron microscopy immunohistochemistry in rodent brain\",\n      \"pmids\": [\"15593368\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct evidence for a transcriptional regulatory function in neurons\", \"Nuclear binding partners not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The discovery that RGS10-null osteoclast precursors lack RANKL-induced Ca²⁺ oscillations and NFATc1 activation, and that RGS10 competitively binds calmodulin and PIP3, established a non-canonical, G protein-independent role in osteoclast differentiation.\",\n      \"evidence\": \"Rgs10 knockout mice, calcium imaging, competitive binding assays, NFATc1 rescue\",\n      \"pmids\": [\"17626792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural basis for RGS10–calmodulin and RGS10–PIP3 interactions not resolved\", \"Whether this mechanism operates in other cell types unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Endogenous RGS10 was confirmed as the functionally relevant GAP governing GIRK channel deactivation in cardiac atrial myocytes, with PKA-mediated Ser168 phosphorylation mediating β-adrenergic crosstalk.\",\n      \"evidence\": \"Adenoviral overexpression and shRNA knockdown, patch-clamp electrophysiology, S168A mutagenesis in rat atrial myocytes\",\n      \"pmids\": [\"18276732\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of RGS10 versus other RGS proteins in cardiac physiology not fully delineated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"RGS10 was shown to oppose chemokine-driven T cell adhesion strengthening by attenuating Gαi-dependent Vav1–Rac1 activation, placing it as a negative regulator of integrin-mediated immune cell trafficking.\",\n      \"evidence\": \"siRNA/overexpression in T cells, shear-stress adhesion assay, constitutively active Rac1 rescue\",\n      \"pmids\": [\"21705617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RGS10 directly interacts with Vav1 or acts solely through Gαi not determined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"RGS10-mediated neuroprotection against TNF cytotoxicity was shown to require PKA phosphorylation at Ser168 and to operate through a PKA→phospho-CREB pathway, linking the nuclear translocation event to a survival output.\",\n      \"evidence\": \"Stable overexpression of WT and S168A RGS10, pharmacological pathway inhibition, phospho-CREB analysis in MN9D cells\",\n      \"pmids\": [\"22564151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets of the RGS10–CREB axis not identified\", \"In vivo neuroprotection not demonstrated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"RGS10-null macrophages exhibited exaggerated M1 and impaired M2 responses, establishing RGS10 as a required checkpoint for macrophage polarization balance.\",\n      \"evidence\": \"Rgs10⁻/⁻ peritoneal and bone marrow-derived macrophages, cytokine ELISA, phagocytosis assays\",\n      \"pmids\": [\"24278459\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism linking RGS10 to M2 gene induction not elucidated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"HDAC1 and DNMT1 were found to directly bind RGS10 promoters and silence its expression in chemoresistant ovarian cancer cells, revealing an epigenetic mechanism of RGS10 downregulation with therapeutic implications.\",\n      \"evidence\": \"ChIP, siRNA knockdown, HDAC/DNMT inhibition, cisplatin sensitivity assay\",\n      \"pmids\": [\"24475290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific CpG methylation sites at RGS10 promoter not mapped\", \"In vivo therapeutic validation lacking\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"RGS10 suppression elevated GTP-bound Rheb and activated mTOR effectors, suggesting RGS10 acts as a GAP for the small GTPase Rheb to restrain mTOR signaling—a non-canonical substrate outside the Gαi family.\",\n      \"evidence\": \"siRNA knockdown, GTP-Rheb pull-down, mTOR pathway immunoblotting, pharmacological mTOR inhibition\",\n      \"pmids\": [\"26319900\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct GAP activity toward Rheb not reconstituted with purified proteins\", \"Single-lab finding without independent replication\", \"Structural basis for Rheb recognition not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"LPS-induced HDAC1 recruitment and histone deacetylation at the Rgs10 promoter in microglia established a feed-forward inflammatory loop: inflammation silences RGS10, which in turn amplifies inflammation.\",\n      \"evidence\": \"ChIP for HDAC1 and acetyl-H3 at Rgs10 promoter, HDAC inhibitor treatment, LPS activation in BV2/primary microglia and nerve injury model\",\n      \"pmids\": [\"28031332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other HDACs contribute in vivo not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Two key advances established that (1) RGS10 inhibits COX-2 and TNFα through a mechanism independent of G protein binding, and (2) in platelets, RGS10 is sequestered by spinophilin/14-3-3γ and released upon activation, defining both a G protein-independent anti-inflammatory pathway and a scaffold-regulated availability mechanism.\",\n      \"evidence\": \"G protein-binding-deficient RGS10 mutant retaining anti-inflammatory function; pertussis toxin insensitivity; RGS10⁻/⁻ platelet signaling assays; co-IP with spinophilin and 14-3-3γ; in vivo thrombosis model\",\n      \"pmids\": [\"30049816\", \"30150297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target of G protein-independent anti-inflammatory action not identified\", \"Structural basis for spinophilin/14-3-3γ sequestration unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"A full PI3K→NF-κB→p300→TNFα→HDAC1-3 signaling cascade was delineated for LPS-induced RGS10 silencing, and human RGS10 variants with altered PKA phosphorylation and mislocalization were linked to defective lymphocyte chemotaxis, connecting variant biology to immune function.\",\n      \"evidence\": \"Pharmacological epistasis and CRISPR KO in macrophages; patient-derived variant expression with GAP, phosphorylation, localization, and chemotaxis assays\",\n      \"pmids\": [\"34339853\", \"34315806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clinical phenotype spectrum of human RGS10 variants not fully defined\", \"Whether variants affect non-immune RGS10 functions not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"RGS10 was found to interact with the phosphatase PTPN2 in CD4⁺ T cells, mediating inhibition of STAT1/STAT3 phosphorylation and restricting Th1/Th17 differentiation, extending RGS10's immune-regulatory reach to JAK-STAT signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, RGS10 KO DSS-colitis mouse model, phospho-STAT immunoblotting, scRNA-seq\",\n      \"pmids\": [\"39428350\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PTPN2–RGS10 interaction not validated by reciprocal IP or with purified proteins\", \"Whether PTPN2 interaction is direct or part of a larger complex not resolved\", \"Mechanistic link between RGS10 binding and PTPN2 phosphatase activity not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of RGS10's direct target in G protein-independent NF-κB suppression, whether RGS10 is a bona fide Rheb GAP, the structural basis for its interactions with calmodulin/PIP3/spinophilin/14-3-3γ, and the full phenotypic spectrum of human RGS10 deficiency.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct molecular target of G protein-independent anti-inflammatory activity unidentified\", \"Rheb GAP activity not reconstituted with purified components\", \"No high-resolution structure of full-length RGS10 or its complexes with non-Gα partners\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 9, 16, 18]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 5, 15]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 8, 9, 15]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 11, 16, 18, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNAI3\",\n      \"GNAZ\",\n      \"GNAO1\",\n      \"SPP1\",\n      \"YWHAG\",\n      \"PTPN2\",\n      \"CALM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}